Search Results - "Ashby, Emma L"
-
1
Pathophysiology of white matter perfusion in Alzheimer’s disease and vascular dementia
Published in Brain (London, England : 1878) (01-05-2014)“…The pathophysiology of white matter hypoperfusion is poorly understood. Barker et al. quantify ante-mortem hypoperfusion by measuring myelin proteins…”
Get full text
Journal Article -
2
Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex
Published in Journal of Alzheimer's disease (22-02-2016)“…Epidemiological data associate hypertension with a predisposition to Alzheimer's disease (AD), and a number of postmortem and in vivo studies also demonstrate…”
Get more information
Journal Article -
3
Assessment of activation of the plasma kallikrein-kinin system in frontal and temporal cortex in Alzheimer's disease and vascular dementia
Published in Neurobiology of aging (01-07-2012)“…Abstract Decreased cerebral blood flow and blood-brain barrier disruption are features of Alzheimer's disease (AD). The plasma kallikrein-kinin system…”
Get full text
Journal Article -
4
Altered Expression of Human Mitochondrial Branched Chain Aminotransferase in Dementia with Lewy Bodies and Vascular Dementia
Published in Neurochemical research (01-01-2017)“…Cytosolic and mitochondrial human branched chain aminotransferase (hBCATc and hBCATm, respectively) play an integral role in brain glutamate metabolism…”
Get full text
Journal Article -
5
Kallikrein-related peptidase 6 in Alzheimer's disease and vascular dementia
Published in Brain research (06-12-2010)“…Abstract Human kallikrein-related peptidase 6 (KLK6) is highly expressed in the central nervous system. Although the physiological roles of this serine…”
Get full text
Journal Article -
6
Investigation of Aβ phosphorylated at serine 8 (pAβ) in Alzheimer's disease, dementia with Lewy bodies and vascular dementia
Published in Neuropathology and applied neurobiology (01-06-2015)“…Aims Deposition of amyloid beta (Aβ) in the brain is one of the defining abnormalities of Alzheimer's disease (AD). Phosphorylation of Aβ at serine 8 (pAβ) has…”
Get full text
Journal Article -
7
The association of angiotensin-converting enzyme with biomarkers for Alzheimer's disease
Published in Alzheimer's research & therapy (15-05-2014)“…Lower angiotensin-converting enzyme (ACE) activity could increase the risk of Alzheimer's disease (AD) as ACE functions to degrade amyloid-β (Aβ). Therefore,…”
Get full text
Journal Article -
8
Angiotensin-converting enzyme in cerebrospinal fluid and risk of brain atrophy
Published in Journal of Alzheimer's disease (01-01-2015)“…Higher angiotensin-converting enzyme (ACE) activity might increase the risk of Alzheimer's disease by increasing blood pressure, and subsequent development of…”
Get more information
Journal Article -
9
Investigation of A β phosphorylated at serine 8 (p A β) in A lzheimer's disease, dementia with L ewy bodies and vascular dementia
Published in Neuropathology and applied neurobiology (01-06-2015)“…Aims Deposition of amyloid beta ( A β) in the brain is one of the defining abnormalities of A lzheimer's disease ( AD ). Phosphorylation of A β at serine 8 (p…”
Get full text
Journal Article -
10
Investigation of A[beta] phosphorylated at serine 8 (pA[beta]) in Alzheimer's disease, dementia with Lewy bodies and vascular dementia
Published in Neuropathology and applied neurobiology (01-06-2015)“…Aims Deposition of amyloid beta (A[beta]) in the brain is one of the defining abnormalities of Alzheimer's disease (AD). Phosphorylation of A[beta] at serine 8…”
Get full text
Journal Article